BIOPIX-T Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $518K

  • Investors
  • 4

BIOPIX-T General Information

Description

Developer and manufacturer of novel portable molecular diagnostic device designed for point of care. The company's device can be used for the detection of viruses both from crude samples and also from extracted ones, enabling healthcare providers with an affordable, easy-to-use, and accurate device for improvement in genetic testing.

Contact Information

Website
www.biopix-t.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 North Plastira street
  • Science and Technology Park of Crete
  • Voutes, Heraklion 700 13
  • Greece
+30 281
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Manufacturing, HealthTech
Corporate Office
  • 100 North Plastira street
  • Science and Technology Park of Crete
  • Voutes, Heraklion 700 13
  • Greece
+30 281

BIOPIX-T Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIOPIX-T Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Jun-2023 $518K Completed Generating Revenue
4. Early Stage VC 05-Nov-2021 Completed Generating Revenue
3. Seed Round 01-Oct-2020 Completed Generating Revenue
2. Grant 11-Aug-2020 $2.79M Completed Generating Revenue
1. Grant 01-Nov-2018 $57.4K Completed Startup
To view BIOPIX-T’s complete valuation and funding history, request access »

BIOPIX-T Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of novel portable molecular diagnostic device designed for point of care. The company's devic
Diagnostic Equipment
Voutes, Greece
16 As of 2024

Emeryville, CA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BIOPIX-T Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lucira Health Formerly VC-backed Emeryville, CA
Biomeme Venture Capital-Backed Philadelphia, PA
Cepheid Formerly VC-backed Sunnyvale, CA
Abbott Diagnostics Failed Transaction (M&A) Lake Forest, IL
DNANudge Venture Capital-Backed London, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

BIOPIX-T Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

BIOPIX-T Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4180128-A1 Pocket-size device for isothermal nucleic acid amplification Pending 12-Nov-2021
CA-3237477-A1 Pocket-size device for isothermal nucleic acid amplification Pending 12-Nov-2021
CA-3115732-A1 Method and apparatus for performing a real-time colorimetric nucleic acid amplification assay Pending 31-Oct-2018
AU-2019370720-A1 Method and apparatus for performing a real-time colorimetric nucleic acid amplification assay Pending 31-Oct-2018
US-20220010369-A1 Method and apparatus for performing a real-time colorimetric nucleic acid amplification assay Pending 31-Oct-2018 C12Q1/6851
To view BIOPIX-T’s complete patent history, request access »

BIOPIX-T Executive Team (6)

Name Title Board Seat
George Papadakis Co-Founder & Chief Executive Officer
Konstantinos Hatzakis Chief Financial Officer
Electra Gizeli Co-Founder & Chief Scientific Officer
Nikolaos Fikas Co-Founder & Head of Software Engineering
You’re viewing 4 of 6 executive team members. Get the full list »

BIOPIX-T Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BIOPIX-T Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eleven Ventures Venture Capital Minority
Metavallon VC Venture Capital Minority
European Commission Government
Proof of Concept Other
To view BIOPIX-T’s complete investors history, request access »

Ready to get started?

Request a free trial

BIOPIX-T FAQs

  • When was BIOPIX-T founded?

    BIOPIX-T was founded in 2018.

  • Who is the founder of BIOPIX-T?

    George Papadakis, Electra Gizeli, Alexandros Pantazis, Sergios Katsaros, and Nikolaos Fikas are the founders of BIOPIX-T.

  • Who is the CEO of BIOPIX-T?

    George Papadakis is the CEO of BIOPIX-T.

  • Where is BIOPIX-T headquartered?

    BIOPIX-T is headquartered in Voutes, Greece.

  • What is the size of BIOPIX-T?

    BIOPIX-T has 16 total employees.

  • What industry is BIOPIX-T in?

    BIOPIX-T’s primary industry is Diagnostic Equipment.

  • Is BIOPIX-T a private or public company?

    BIOPIX-T is a Private company.

  • What is BIOPIX-T’s current revenue?

    The current revenue for BIOPIX-T is .

  • How much funding has BIOPIX-T raised over time?

    BIOPIX-T has raised $901K.

  • Who are BIOPIX-T’s investors?

    Eleven Ventures, Metavallon VC, European Commission, and Proof of Concept have invested in BIOPIX-T.

  • Who are BIOPIX-T’s competitors?

    Lucira Health, Biomeme, Cepheid, Abbott Diagnostics, and DNANudge are competitors of BIOPIX-T.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »